SecurityOVIT / OncoVista Innovative Therapies, Inc. (68232J105)
IndustryPharmaceutical Preparations
Institutional Owners2
Institutional Shares87,600 - 0.37%
Common Stock Shares Outstanding23,558,530 shares (as of 2015-09-30)
Institutional Value$ 2,000 USD

Institutional Stock Ownership and Shareholders

OncoVista Innovative Therapies, Inc. (OTC:OVIT) has 2 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 87,600 shares. Largest shareholders include Osborn Rohs Williams & Donohoe Ltd, and Simmons Bank.

OncoVista Innovative Therapies, Inc. (OTC:OVIT) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

File DateFormInvestor Opt Prev Shares Current Shares Change
Prev Value (x$1000) Current Value (x$1000) Change
2018-02-13 13F-HR Simmons Bank 10,000 10,000 0.00 0 0
2018-01-22 13F-HR Osborn Rohs Williams & Donohoe Ltd 77,600 77,600 0.00 1 2 100.00

CUSIP: 68232J105